The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Cancer Biomarker-Global Market Insights and Sales Trends 2025

Cancer Biomarker-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1817739

No of Pages : 110

Ask Your Query
Synopsis
Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
The global Cancer Biomarker market size is expected to reach US$ 42170 million by 2029, growing at a CAGR of 11.4% from 2023 to 2029. The market is mainly driven by the significant applications of Cancer Biomarker in various end use industries. The expanding demands from the Diagnostics, Research and Others,, are propelling Cancer Biomarker market. Protein Biomarker, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Genetic Biomarker segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cancer Biomarker market, driven by demand from China, the second largest economy with some signs of stabilising, the Cancer Biomarker market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cancer Biomarker, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cancer Biomarker market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cancer Biomarker market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cancer Biomarker sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cancer Biomarker covered in this report include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA and Merck & Co., etc.
The global Cancer Biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Thermo Fisher Scientific
Bio-Rad Laboratories
Roche Diagnostics
Qiagen
Illumina
GE Healthcare
Agilent Technologies
Biomérieux SA
Merck & Co.
Abbott Laboratories
Becton, Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic
Quest Diagnostics
Global Cancer Biomarker market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cancer Biomarker market, Segment by Type:
Protein Biomarker
Genetic Biomarker
Global Cancer Biomarker market, by Application
Diagnostics
Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cancer Biomarker in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Cancer Biomarker Market Overview
1.1 Cancer Biomarker Product Overview
1.2 Cancer Biomarker Market Segment by Type
1.2.1 Protein Biomarker
1.2.2 Genetic Biomarker
1.3 Global Cancer Biomarker Market Size by Type
1.3.1 Global Cancer Biomarker Market Size Overview by Type (2018-2029)
1.3.2 Global Cancer Biomarker Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cancer Biomarker Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cancer Biomarker Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cancer Biomarker Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cancer Biomarker Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cancer Biomarker Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cancer Biomarker Sales Breakdown by Type (2018-2023)
2 Global Cancer Biomarker Market Competition by Company
2.1 Global Top Players by Cancer Biomarker Sales (2018-2023)
2.2 Global Top Players by Cancer Biomarker Revenue (2018-2023)
2.3 Global Top Players by Cancer Biomarker Price (2018-2023)
2.4 Global Top Manufacturers Cancer Biomarker Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cancer Biomarker Market Competitive Situation and Trends
2.5.1 Cancer Biomarker Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cancer Biomarker Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2022)
2.7 Date of Key Manufacturers Enter into Cancer Biomarker Market
2.8 Key Manufacturers Cancer Biomarker Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cancer Biomarker Status and Outlook by Region
3.1 Global Cancer Biomarker Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cancer Biomarker Historic Market Size by Region
3.2.1 Global Cancer Biomarker Sales in Volume by Region (2018-2023)
3.2.2 Global Cancer Biomarker Sales in Value by Region (2018-2023)
3.2.3 Global Cancer Biomarker Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cancer Biomarker Forecasted Market Size by Region
3.3.1 Global Cancer Biomarker Sales in Volume by Region (2024-2029)
3.3.2 Global Cancer Biomarker Sales in Value by Region (2024-2029)
3.3.3 Global Cancer Biomarker Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cancer Biomarker by Application
4.1 Cancer Biomarker Market Segment by Application
4.1.1 Diagnostics
4.1.2 Research
4.1.3 Others
4.2 Global Cancer Biomarker Market Size by Application
4.2.1 Global Cancer Biomarker Market Size Overview by Application (2018-2029)
4.2.2 Global Cancer Biomarker Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cancer Biomarker Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cancer Biomarker Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cancer Biomarker Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cancer Biomarker Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cancer Biomarker Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cancer Biomarker Sales Breakdown by Application (2018-2023)
5 North America Cancer Biomarker by Country
5.1 North America Cancer Biomarker Historic Market Size by Country
5.1.1 North America Cancer Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cancer Biomarker Sales in Volume by Country (2018-2023)
5.1.3 North America Cancer Biomarker Sales in Value by Country (2018-2023)
5.2 North America Cancer Biomarker Forecasted Market Size by Country
5.2.1 North America Cancer Biomarker Sales in Volume by Country (2024-2029)
5.2.2 North America Cancer Biomarker Sales in Value by Country (2024-2029)
6 Europe Cancer Biomarker by Country
6.1 Europe Cancer Biomarker Historic Market Size by Country
6.1.1 Europe Cancer Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cancer Biomarker Sales in Volume by Country (2018-2023)
6.1.3 Europe Cancer Biomarker Sales in Value by Country (2018-2023)
6.2 Europe Cancer Biomarker Forecasted Market Size by Country
6.2.1 Europe Cancer Biomarker Sales in Volume by Country (2024-2029)
6.2.2 Europe Cancer Biomarker Sales in Value by Country (2024-2029)
7 Asia-Pacific Cancer Biomarker by Region
7.1 Asia-Pacific Cancer Biomarker Historic Market Size by Region
7.1.1 Asia-Pacific Cancer Biomarker Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cancer Biomarker Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cancer Biomarker Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cancer Biomarker Forecasted Market Size by Region
7.2.1 Asia-Pacific Cancer Biomarker Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cancer Biomarker Sales in Value by Region (2024-2029)
8 Latin America Cancer Biomarker by Country
8.1 Latin America Cancer Biomarker Historic Market Size by Country
8.1.1 Latin America Cancer Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cancer Biomarker Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cancer Biomarker Sales in Value by Country (2018-2023)
8.2 Latin America Cancer Biomarker Forecasted Market Size by Country
8.2.1 Latin America Cancer Biomarker Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cancer Biomarker Sales in Value by Country (2024-2029)
9 Middle East and Africa Cancer Biomarker by Country
9.1 Middle East and Africa Cancer Biomarker Historic Market Size by Country
9.1.1 Middle East and Africa Cancer Biomarker Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cancer Biomarker Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cancer Biomarker Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cancer Biomarker Forecasted Market Size by Country
9.2.1 Middle East and Africa Cancer Biomarker Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cancer Biomarker Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Thermo Fisher Scientific
10.1.1 Thermo Fisher Scientific Company Information
10.1.2 Thermo Fisher Scientific Introduction and Business Overview
10.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Thermo Fisher Scientific Cancer Biomarker Products Offered
10.1.5 Thermo Fisher Scientific Recent Development
10.2 Bio-Rad Laboratories
10.2.1 Bio-Rad Laboratories Company Information
10.2.2 Bio-Rad Laboratories Introduction and Business Overview
10.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bio-Rad Laboratories Cancer Biomarker Products Offered
10.2.5 Bio-Rad Laboratories Recent Development
10.3 Roche Diagnostics
10.3.1 Roche Diagnostics Company Information
10.3.2 Roche Diagnostics Introduction and Business Overview
10.3.3 Roche Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Diagnostics Cancer Biomarker Products Offered
10.3.5 Roche Diagnostics Recent Development
10.4 Qiagen
10.4.1 Qiagen Company Information
10.4.2 Qiagen Introduction and Business Overview
10.4.3 Qiagen Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Qiagen Cancer Biomarker Products Offered
10.4.5 Qiagen Recent Development
10.5 Illumina
10.5.1 Illumina Company Information
10.5.2 Illumina Introduction and Business Overview
10.5.3 Illumina Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Illumina Cancer Biomarker Products Offered
10.5.5 Illumina Recent Development
10.6 GE Healthcare
10.6.1 GE Healthcare Company Information
10.6.2 GE Healthcare Introduction and Business Overview
10.6.3 GE Healthcare Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GE Healthcare Cancer Biomarker Products Offered
10.6.5 GE Healthcare Recent Development
10.7 Agilent Technologies
10.7.1 Agilent Technologies Company Information
10.7.2 Agilent Technologies Introduction and Business Overview
10.7.3 Agilent Technologies Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Agilent Technologies Cancer Biomarker Products Offered
10.7.5 Agilent Technologies Recent Development
10.8 Biomérieux SA
10.8.1 Biomérieux SA Company Information
10.8.2 Biomérieux SA Introduction and Business Overview
10.8.3 Biomérieux SA Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Biomérieux SA Cancer Biomarker Products Offered
10.8.5 Biomérieux SA Recent Development
10.9 Merck & Co.
10.9.1 Merck & Co. Company Information
10.9.2 Merck & Co. Introduction and Business Overview
10.9.3 Merck & Co. Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck & Co. Cancer Biomarker Products Offered
10.9.5 Merck & Co. Recent Development
10.10 Abbott Laboratories
10.10.1 Abbott Laboratories Company Information
10.10.2 Abbott Laboratories Introduction and Business Overview
10.10.3 Abbott Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Abbott Laboratories Cancer Biomarker Products Offered
10.10.5 Abbott Laboratories Recent Development
10.11 Becton, Dickinson and Company
10.11.1 Becton, Dickinson and Company Company Information
10.11.2 Becton, Dickinson and Company Introduction and Business Overview
10.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Becton, Dickinson and Company Cancer Biomarker Products Offered
10.11.5 Becton, Dickinson and Company Recent Development
10.12 Danaher Corporation
10.12.1 Danaher Corporation Company Information
10.12.2 Danaher Corporation Introduction and Business Overview
10.12.3 Danaher Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Danaher Corporation Cancer Biomarker Products Offered
10.12.5 Danaher Corporation Recent Development
10.13 Myriad Genetics
10.13.1 Myriad Genetics Company Information
10.13.2 Myriad Genetics Introduction and Business Overview
10.13.3 Myriad Genetics Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Myriad Genetics Cancer Biomarker Products Offered
10.13.5 Myriad Genetics Recent Development
10.14 Sysmex Corporation
10.14.1 Sysmex Corporation Company Information
10.14.2 Sysmex Corporation Introduction and Business Overview
10.14.3 Sysmex Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Sysmex Corporation Cancer Biomarker Products Offered
10.14.5 Sysmex Corporation Recent Development
10.15 Hologic
10.15.1 Hologic Company Information
10.15.2 Hologic Introduction and Business Overview
10.15.3 Hologic Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Hologic Cancer Biomarker Products Offered
10.15.5 Hologic Recent Development
10.16 Quest Diagnostics
10.16.1 Quest Diagnostics Company Information
10.16.2 Quest Diagnostics Introduction and Business Overview
10.16.3 Quest Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Quest Diagnostics Cancer Biomarker Products Offered
10.16.5 Quest Diagnostics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cancer Biomarker Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cancer Biomarker Industrial Chain Analysis
11.4 Cancer Biomarker Market Dynamics
11.4.1 Cancer Biomarker Industry Trends
11.4.2 Cancer Biomarker Market Drivers
11.4.3 Cancer Biomarker Market Challenges
11.4.4 Cancer Biomarker Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cancer Biomarker Distributors
12.3 Cancer Biomarker Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock